Grignon D J, Abdel-Malak M, Mertens W C, Sakr W A, Shepherd R R
Department of Pathology, Victoria Hospital, London Regional Cancer Center, Canada.
Mod Pathol. 1994 Feb;7(2):186-9.
Expression of two GST isoenzymes (alpha and pi) was assessed immunohistochemically in 46 cases of renal cell carcinoma (RCC) for which clinical follow-up was available. In the normal kidney GST alpha stained most intensely in the proximal convoluted tubules and GST pi in distal tubules/collecting ducts. All 46 tumors studied stained positively for GST alpha with most demonstrating strong cytoplasmic and nuclear reactivity. GST pi immunostaining was positive in 35/46 cases (76%). Five-year survival for patients with GST pi positive tumors was 88% versus 50% for those with GST pi negative tumors (P < 0.008). Loss of GST mRNA has been reported in RCC and it has been suggested that this may represent a dedifferentiation program in RCC. These data support this hypothesis and further indicate a potential value for GST pi as a prognostic indicator in RCC.
采用免疫组织化学方法评估了46例有临床随访资料的肾细胞癌(RCC)中两种谷胱甘肽S-转移酶(GST)同工酶(α和π)的表达情况。在正常肾脏中,GSTα在近端曲管中染色最深,而GSTπ在远端小管/集合管中染色最深。所研究的46个肿瘤均对GSTα呈阳性染色,大多数表现出强烈的细胞质和细胞核反应性。GSTπ免疫染色在35/46例(76%)中呈阳性。GSTπ阳性肿瘤患者的5年生存率为88%,而GSTπ阴性肿瘤患者为50%(P<0.008)。已有报道称RCC中存在GST mRNA缺失,有人认为这可能代表RCC中的一种去分化程序。这些数据支持这一假设,并进一步表明GSTπ作为RCC预后指标的潜在价值。